Board of Directors

  • Mr Oliver de Giorgio-Miller - Chairman

    Mr Oliver de Giorgio-Miller

    Chairman

    Oliver has a wealth of experience in the management and commercial advancement of life science companies.  He has worked for over 30 years with several global pharmaceutical and medical device companies including Schering AG, Hoffman la Roche, Intavent-Orthofix and Photo Therapeutics, a Cancer Research UK company and he has extensive experience advising a number of other early stage biopharmaceutical and medical device companies

  • Dr Satu Vainikka - Chief Executive Officer
    More

    Dr Satu Vainikka

    Chief Executive Officer

    Satu has many years experience of the biotechnology industry, including extensive first hand experience of equity financing, business management and developing life science technology into commercial enterprises. Prior to her current role as CEO of Valirx, she was a founder, director and CEO of Cronos Therapeutics Limited.

  • Dr George Morris - Chief Operations Officer
    More

    Dr George Morris

    Chief Operations Officer

    George has over 25 years' experience in biological and medical research, and financial services. In the past he has worked for Guy‘s hospital medical school department of medicine, King’s college and University College London. As a Research Scientist, He is an author of numerous books and articles on refereed papers, approximately 70 abstracts, short reports and posters, and an inventor of multiple patents.

  • Mr Gerry Desler - Chief Financial Officer
    More

    Mr Gerry Desler

    Chief Financial Officer

    Gerry is a chartered accountant, who qualified in 1968 with a City firm, before becoming a partner in 1970. Between 1985 to 1990 he was the Senior Partner. During his time in the City, he has specialised in consultancy work, much of it involving funding and venture capital.

  • Mr Kevin Alexander - Non-Executive Director

    Mr Kevin Alexander

    Non-Executive Director

    Kevin is a qualified solicitor in England and an attorney in New York and he was a partner at major law firms in both London and the United States for over 25 years. Since leaving the law he has been involved in forming and managing various businesses, both private and public. Kevin is a director of Valirx Plc, and joined the board in September 2006. He has an MA in law from Cambridge University.

  • Mr Seppo Mäkinen - Non-Executive Director
    More

    Mr Seppo Mäkinen

    Non-Executive Director

    Seppo Mäkinen has more than 25 years of senior advisory and executive experience in board level strategic leadership and venture capital management on life science, his special expertise is on medtech / diagnostics.